About 20% of acute pancreatitis cases develop necrosis and have a high risk
of inflammatory and infectious complications and a high mortality rate. Ac
ute pancreatitis has a variety of causes and despite years of research its
pathogenesis remains complex and obscure. Both local and systemic inflammat
ory responses play key roles in the pathophysiology of this disorder. Treat
ment plans continue to rely on supportive care without proven specific ther
apies. Pancreatic rest and use of total parenteral nutrition (TPN) were the
gold standard for nutritional support of these challenging patients. Becau
se numerous studies in other critically ill patients demonstrated benefits
of enteral nutrition, recent investigations compared TPN to enteral nutriti
on in acute pancreatitis. These studies indicated that enteral nutrition de
livered into the jejunum was tolerated well, even in patients with severe a
cute pancreatitis. "Mild" cases of pancreatitis should improve and tolerate
oral nutrition within a few days. In contrast, "severe" cases of pancreati
tis or those with a protracted clinical course require nutritional support
to aid in preventing adverse effects of starvation and nutrient deficiencie
s. Current recommendations are to attempt enteral nutrition in patients wit
h acute pancreatitis prior to instituting TPN. Further studies to determine
optimal nutrient composition are warranted and should investigate the poss
ibility of modulating the inflammatory response induced by pancreatitis to
improve outcomes.